Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nexam Chemical presents third quarter for 2021 on October the 21[st] at 11:00 CET

On October the 21[st] 2021 at 08:00 CET Nexam Chemical will publish the report for the third quarter in 2021. The report and the presentation will be available at the company website.In connection with the release - analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Johan Arvidsson, CEO will present and comment the report. The presentation will be held in Swedish via a conference call or audio webcast at https://financialhearings.com/event/13216. If you do not intend to ask questions at the end of the presentation, please

Free Background Checks in Montana for Looking Up Public Records: The Best MT Criminal and Arrest Records Search Engines Online

An official Montana background check is used by police and employers to verify a person's fitness and/or file charges. The Montana Department of Justice handles an official background check. Members of the general public may obtain criminal history records on any Montana resident, however, the information released is restricted by law. Unofficial background checks aren't permitted for employment, loans, or tenancy purposes, but they may be useful for learning more about: · Neighbors. · Friends. · Enemies. · Co-workers. · Romantic interests. · Relatives. Unofficial

Notice to convene an extraordinary general meeting of Aquaporin A/S regarding proposed changes to the Board of Directors

Company announcement no. 21/2021 The Board of Directors of Aquaporin A/S, CVR no. 28 31 56 94, (the “Company”) hereby convenes an extraordinary general meeting of the Company to be held on Monday, 8 November 2021 at 17:00 (CET) at Axel Towers, Gorrissen Federspiel, Axeltorv 2, DK-1609 Copenhagen V, Denmark for the purpose of electing two new members to the Board of Directors. The Board of Directors proposes election of Anupam Bhargava as a new member of the Board of Directors. As described in the prospectus published by Aquaporin A/S on 14 June 2021, the Board of Directors decided

Company Announcement No 103, 2021 - Addendum to Nordea Kredits final terms

The following security code has been added to the final terms of non-callable covered mortgage bonds (SDRO):   Non-callable variable interest rate annuity bond with option for interest-only period of 1-10 years ISIN code Nom.interest Name Opening Closing Maturity  Currency rate/ date date date Maturity    DK0002052497    0,00% 2025   NDAEURIBOR3  15/10  31/10 01/01  EUR OA25RF   -2021   -2024   -2025     Reference is otherwise made to the

Study of animals with diabetes shows effect in Dicot’s drug candidate

Press release: Uppsala, October 14, 2021. Potency drug developer Dicot has just completed a study on rats with diabetes and proven erectile dysfunction. The company's drug candidate demonstrated significantly improved erections compared to vehicle.In August 2021, Dicot released the results of its latest animal study on healthy rats, which concluded that the drug candidate LIB-01 has a longer effect on erection than other drugs on the market today, and that the effect increases over time. The company is now publishing a new study, in collaboration with the French contract laboratory

Lundbeck receives exclusive rights to APB-A1, an innovative phase I-ready bio-therapeutic for the treatment of neuroimmune diseases from AprilBio

· APB-A1 targets the clinically validated CD40L/CD40 biology which is central to a wide range of attractive neuroimmune indications · APB-A1 is a novel and differentiated biotherapeutic with strong preclinical evidence  · Deal accelerates the Lundbeck strategy to expand R&D activities within neuroimmunology · Follows the Lundbeck strategy of tractable and biomarker driven development programs in diseases of high unmet needH. Lundbeck A/S (Lundbeck) announced that it has entered into a definitive agreement with AprilBio Co., Ltd. (AprilBio), a biopharmaceutical company based in

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV

PRESS RELEASE Stockholm, 14 October 2021 Today the Net Asset Values of the P Capital Partners IV participation loan debentures is at the close of business on 13 October 2021 EUR 104.17 per each of the series A1 participation loan debentures. The Net Asset Value of P Capital Partners IV participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net Asset Value has been set, as a result of P Capital Partners IV increasing its contributed capital by EUR 19.4 million, through the issuance of 192,800

ANNOUNCEMENT OF THE NAV OF P CAPITAL PARTNERS IV B

PRESS RELEASE Stockholm, 14 October 2021 Today the Net Asset Values of the P Capital Partners IV B participation loan debentures are being announced. At the close of business on 13 October 2021, the Net Asset Value of the series A1 participation loan debentures amounted to EUR 103.36 each, and the Net Asset Value of the series B participation loan debenture amounted to EUR 1,034.44 each. The Net Asset Value of P Capital Partners IV B participation loan debentures is to be calculated at the close of each quarter and in conjunction with a capital increase or decrease. The Net

EQT becomes the first private markets firm to set science based targets

EQT accelerates its journey to address climate change by defining ambitious greenhouse gas emission (“GHG”) reduction targets, encompassing both its own and its portfolio investments’ operations EQT becomes the first private markets firm to formalize science based targets through the Science Based Targets initiative  (“SBTi”)The science based targets (“SBTs”) will become a central part of EQT’s active ownership strategy and climate-related value creation drivers across all investmentsEQT AB is proud to announce that EQT’s science based targets have

Clavister Wins new Defence Engagement for National Security

14 October 2021 – Örnsköldsvik, Sweden – Clavister, a leader in European carrier-grade cybersecurity solutions for mission-critical applications, today announces a new customer engagement in the defence sector.With the new engagement, Clavister will be providing cybersecurity to an undisclosed customer in the defence sector for a project related to national security within the European Union. The initial order to Clavister amounts to ca 3 MSEK, and the engagement is expected to grow to at least 10 MSEK per year after a ramp-up period of twelve to eighteen months and continue to run for a

Wyld Networks strengthens its commercial position with published patent application and secured trademarks

Satellite IoT company Wyld Networks strengthens its commercial position as the company’s first international patent application protecting Wyld’s cutting-edge technology has been published. In the strategic efforts to protect the company’s IP assets and long-term value, Wyld Networks has also secured key trademarks associated with the Wyld brand and products.“We are very pleased to have got our first international patent application published as well as having secured several key trademarks. As a growing tech company, our intellectual property is a strategic asset and – alongside the people

Preliminary figures show a positive EBITDA-result amounting to SEK 700,000 and a positive cash flow for the month of September

Preliminary figures show a positive EBITDA-result amounting to SEK 700,000 for the month of September. The continued good development of SpectrumOne together with rising revenues has led to the company generating a positive EBITDA result during September and a positive cash flow during the same month. The final figures will be reported in the upcoming q3-report on October 29 together with the numbers for July and August. Hosni Teque-Omeirat CEO of SpectrumOne commented on the preliminary figures  “We have since the start of the transformation of this company had several milestones and

Fimea inspected Nightingale’s regulatory compliance with the requirements for manufacturer of medical device

Press release, 14 October 2021 at 9:50 a.m. (EEST) The authority supervising regulatory compliance of medical devices and actors in the industry, Fimea, has as part of its market surveillance inspected Nightingale Health Plc’s (“Nightingale”) regulatory compliance with the requirements for manufacturer of medical device. The inspection included an evaluation of the manufacturer’s compliance with statutory obligations and required quality assurance, including among other things fulfillment of risk management, change management, document management, customer feedback management and control

Solstad Offshore, Aker Solutions and DeepOcean create offshore renewables alliance

October 14[th], 2021 – Solstad Offshore ASA (Solstad Offshore), Aker Solutions ASA (Aker Solutions) and DeepOcean Norway AS (DeepOcean) and have joined forces to create Windstaller Alliance. The new partnership aims to provide the world’s most cost-efficient and complete product supply, fabrication and marine services offering within offshore wind. The alliance will also pursue other offshore renewables segments. Windstaller Alliance will combine the already well-established capabilities and expertise of the three offshore industry leaders. This will form an integrated and highly

Genetic Analysis receives important patent allowance in China

OSLO, NORWAY - 14 October 2021: Microbiome DX company Genetic Analysis AS (“GA” or “the Company”) announces that the Company has been awarded an important patent (CN107430644A) by the China National Intellectual Property Agency (CNIPA). The patent entitled “A METHOD FOR DETERMINING GASTROINTESTINAL TRACT DYSBIOSIS” covers the Company’s unique algorithm incorporated in the GA-map® technology for profiling gut microbiota. The positive decision from the Chinese patent authority means that the protection of the GA-map® technology has been substantially strengthened and will further support the

Aker Solutions, DeepOcean and Solstad Offshore Create Offshore Renewables Alliance

October 14, 2021 – International offshore energy suppliers Aker Solutions, DeepOcean and Solstad Offshore have joined forces to create Windstaller Alliance. The new partnership aims to provide the world’s most cost-efficient and complete product supply, fabrication and marine services offering within offshore wind. The alliance will also pursue other offshore renewables segments.Windstaller Alliance will combine the already well-established capabilities and expertise of the three offshore industry leaders. This will form an integrated and highly flexible one-stop-shop provider. The alliance

Improved ESG risk rating for Balco Group

Balco has taken several important steps in its sustainability work. The targeted efforts now yield results in the form of an improved ESG risk rating. In Sustainalytics’ latest valuation of the company, Balco improves its ESG risk rating from 28.6 to 20.8.– It is positive that our focus on sustainability is also reflected in independent assessments. It is proof that the systematic work we conduct has an effect. We are of course not satisfied here, but our goal is to get below 20 next year and thus reach ESG risk rating “Low”, says Johan Fälth, sustainability manager at Balco Group. The

Cantargia receives positive EMA opinion for orphan designation of nadunolimab for treatment of pancreatic cancer

Cantargia AB today announced that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has issued a positive opinion for orphan designation of nadunolimab (CAN04) for treatment of pancreatic cancer. The European Commission is now expected to grant the orphan designation. This provides a range of incentives in the continued clinical development of CAN04 in pancreatic cancer.The interleukin-1 receptor accessory protein (IL1RAP)-binding antibody CAN04 is Cantargia’s lead program and is investigated in multiple clinical trials evaluating combination with

Epiroc wins large mining equipment order in Turkey

Epiroc, a leading productivity and sustainability partner for the mining and infrastructure industries, has won a large order for mining equipment from Eti Bakir in Turkey. The machines will be used to expand three underground copper mines while making the operations as productive and safe as possible.Eti Bakir, Turkey’s largest mining company, has ordered a variety of drill rigs, mine trucks and loaders. The equipment will be used at the Kastamonu Küre, Artvin Murgul and Siirt Madenköy mines. The equipment order is valued at approximately MSEK 140 and was booked in the third quarter 2021.

Sleep Cycle launches Sleep Boot Camp for business

October 14, 2021, Gothenburg - Sleep Cycle launches Sleep Boot Camp; a sleep training program for companies, tailored for everyday use, with the goal of improving sleep and health among employees.Sleep Cycle’s Boot Camp is a four-week long, web-based sleep program developed in collaboration with sleep researcher Frida Rångtell, Ph.D. and psychologist Li Åslund, Ph.D. Each week a new sleep-related topic is introduced and includes course material in the form of videos, articles, coaching, exercises and challenges. The program is designed so participants use the Sleep Cycle app to better

Inzile’s new main owner is introduced

Referring to the completed transaction announced on October 12, Ragnar Åhgren, Chairman of the Board of Inzile, is delighted to welcome eFashion Championship with its owner Enrique Banuelos as the new main shareholder. - As the owner of 100% of eFashion Championship I express my sincere gratitude to all the shareholders of Inzile - especially the founder of Inzile Ragnar Åhgren and Board Member Håkan Örtenholm (who introduced us) - who have unanimously supported the creation of the NEW INZILE, as well as to the current board and management team who have all my support, so that with total

KONE publishes January-September 2021 Interim Report on Thursday, October 28, 2021 at 12:30 p.m. EEST

KONE Corporation, press release, October 14, 2021 at 9.30 a.m. EEST Interim ReportKONE Corporation will publish its Interim Report for the January 1-September 30, 2021 accounting period on Thursday, October 28, 2021 at 12:30 p.m. EEST. The report will be available on www.kone.com after publishing. Press and analyst eventsA Microsoft Teams call for the press, conducted in English, will be held on Thursday, October 28, 2021 at 2:15 p.m. EEST. Journalists are kindly asked to sign up to media@kone.com by Wednesday, October 27, 2021, and they will receive a link to the call upon

Invitation to conference call, October 21 at 13:30 pm CET

Studsvik AB presents its Interim Report for the third quarter 2021 and hereby invites media and analysts to a conference call held in English on Thursday, October 21 at 13:30 CET.Studsvik’s Interim Report for the third quarter 2021 will be distributed at approximately 12:00 CET, October 21. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 13:30 CET. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q3 2021. Conference ID is: 1876858 Description

One third of people globally feel more positive about their homes in the past 12 months, new IKEA research reveals

Eighth annual IKEA Life at Home Report shows how homes have helped and hindered mental health and wellbeing around the world during the pandemic.Live streamed table talk today at 14:00 CET. Register here   · 40 percent of people who felt more positive toward their home in the last 12 months also saw their mental health improve · To achieve better balance at home, people say relaxation (53 percent) and alone time (38 percent) are the most important activities · Family relationships have taken centre stage during the pandemic, but one

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top